BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...Donley as EVP of internal operations and strategy. Donley joins the autoimmune company from Senseonics (AMEX:SENS...
BioCentury | Oct 29, 2012
Financial News

Atossa Genetics amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Aug 27, 2012
Financial News

Atossa Genetics amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Aug 22, 2012
Financial News

Atossa amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex...
BioCentury | Jun 11, 2012
Financial News

Antares financial update

...Antares will voluntarily transfer its shares to NASDAQ from NYSE MKT, formerly the NYSE Amex. The...
BioCentury | Jun 4, 2012
Financial News

ImmunoCellular financial update

...ImmunoCellular began trading on the NYSE MKT, formerly the NYSE Amex, under the symbol "IMUC." Previously...
BioCentury | Apr 30, 2012
Financial News

CorMedix financial update

...CorMedix received notice from NYSE Amex indicating that the company is not in compliance with requirements...
BioCentury | Mar 19, 2012
Financial News

Uluru financial update

...Uluru said it will voluntarily delist its shares from NYSE Amex on or about April 1...
BioCentury | Feb 20, 2012
Financial News

Atossa Genetics proposes IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Feb 15, 2012
Financial News

Atossa files for third IPO try

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex...
Items per page:
1 - 10 of 827
BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...Donley as EVP of internal operations and strategy. Donley joins the autoimmune company from Senseonics (AMEX:SENS...
BioCentury | Oct 29, 2012
Financial News

Atossa Genetics amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Aug 27, 2012
Financial News

Atossa Genetics amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Aug 22, 2012
Financial News

Atossa amends IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex...
BioCentury | Jun 11, 2012
Financial News

Antares financial update

...Antares will voluntarily transfer its shares to NASDAQ from NYSE MKT, formerly the NYSE Amex. The...
BioCentury | Jun 4, 2012
Financial News

ImmunoCellular financial update

...ImmunoCellular began trading on the NYSE MKT, formerly the NYSE Amex, under the symbol "IMUC." Previously...
BioCentury | Apr 30, 2012
Financial News

CorMedix financial update

...CorMedix received notice from NYSE Amex indicating that the company is not in compliance with requirements...
BioCentury | Mar 19, 2012
Financial News

Uluru financial update

...Uluru said it will voluntarily delist its shares from NYSE Amex on or about April 1...
BioCentury | Feb 20, 2012
Financial News

Atossa Genetics proposes IPO

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex. WIR...
BioCentury | Feb 15, 2012
Financial News

Atossa files for third IPO try

...most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex...
Items per page:
1 - 10 of 827